Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen

This article was originally published here

The approval is supported by data from the Phase III GRECO trial and the Phase I AMES trial, which achieved their primary objective of usability and pharmacokinetic (PK)

The post Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply